|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
21:2242-2252
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis of VDR-DNA interactions on direct repeat response elements.
|
|
P.L.Shaffer,
D.T.Gewirth.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The vitamin D receptor (VDR) forms homo- or heterodimers on response elements
composed of two hexameric half-sites separated by 3 bp of spacer DNA. We
describe here the crystal structures at 2.7-2.8 A resolution of the VDR
DNA-binding region (DBD) in complex with response elements from three different
promoters: osteopontin (SPP), canonical DR3 and osteocalcin (OC). These
structures reveal the chemical basis for the increased affinity of VDR for the
SPP response element, and for the poor stability of the VDR-OC complex, relative
to the canonical DR3 response element. The homodimeric protein-protein interface
is stabilized by van der Waals interactions and is predominantly non-polar. An
extensive alpha-helix at the C-terminal end of the VDR DBD resembles that found
in the thyroid hormone receptor (TR), and suggests a mechanism by which VDR and
TR discriminate among response elements. Selective structure-based mutations in
the asymmetric homodimeric interface result in a VDR DBD protein that is
defective in homodimerization but now forms heterodimers with the 9-cis retinoic
acid receptor (RXR) DBD.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1 Protein and DNA constructs used in the structure
determination. (A) The human VDR DBD. Sequence numbers are for
full-length hVDR and those in parentheses refer to the common
hormone receptor DBD numbering scheme. Residues in italics are
disordered in all of the structures. (B) The 18 bp DNA duplexes
used in co-crystallization, shown 5' arrow
3' in the top strand. Half-sites are shown in boxes and are
numbered by base pair. The DR3 sequence contains a direct repeat
of two consensus half-sites. SPP is the mouse osteopontin VDRE
and OC is the rat osteocalcin VDRE. Bases that differ from the
consensus sequence are shaded gray and the structurally
significant changes are highlighted in black. Estimates of
relative binding of VDR DBD homodimers to each sequence are also
shown.
|
 |
Figure 3.
Figure 3 Experimental electron density and homodimeric assembly.
(A) Unbiased experimental electron density from SAD phases. The
map is contoured around the CTE of the upstream subunit of the
VDR DBD−DR3 structure, which is shown as a C[ ]trace.
(B) A portion of the 2F[o] = F[c] electron density map showing
intersubunit dimerization contacts. (C) Stereo view of the
dimerization interface in a van der Waals surface
representation. (A) and (B) were made with Xtalview (McRee,
1999), and (C) was prepared with Ribbons.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(2002,
21,
2242-2252)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.Rochel,
F.Ciesielski,
J.Godet,
E.Moman,
M.Roessle,
C.Peluso-Iltis,
M.Moulin,
M.Haertlein,
P.Callow,
Y.Mély,
D.I.Svergun,
and
D.Moras
(2011).
Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings.
|
| |
Nat Struct Mol Biol,
18,
564-570.
|
 |
|
|
|
|
 |
A.di Masi,
E.De Marinis,
P.Ascenzi,
and
M.Marino
(2009).
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.
|
| |
Mol Aspects Med,
30,
297-343.
|
 |
|
|
|
|
 |
K.K.Hill,
S.C.Roemer,
D.N.Jones,
M.E.Churchill,
and
D.P.Edwards
(2009).
A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.
|
| |
J Biol Chem,
284,
24415-24424.
|
 |
|
|
|
|
 |
F.Claessens,
S.Denayer,
N.Van Tilborgh,
S.Kerkhofs,
C.Helsen,
and
A.Haelens
(2008).
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.
|
| |
Nucl Recept Signal,
6,
e008.
|
 |
|
|
|
|
 |
P.Lu,
G.B.Rha,
M.Melikishvili,
G.Wu,
B.C.Adkins,
M.G.Fried,
and
Y.I.Chi
(2008).
Structural Basis of Natural Promoter Recognition by a Unique Nuclear Receptor, HNF4{alpha}: DIABETES GENE PRODUCT.
|
| |
J Biol Chem,
283,
33685-33697.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.C.Roemer,
J.Adelman,
M.E.Churchill,
and
D.P.Edwards
(2008).
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding.
|
| |
Nucleic Acids Res,
36,
3655-3666.
|
 |
|
|
|
|
 |
K.Saavalainen,
M.I.Tammi,
T.Bowen,
M.L.Schmitz,
and
C.Carlberg
(2007).
Integration of the activation of the human hyaluronan synthase 2 gene promoter by common cofactors of the transcription factors retinoic acid receptor and nuclear factor kappaB.
|
| |
J Biol Chem,
282,
11530-11539.
|
 |
|
|
|
|
 |
M.Jakób,
R.Kołodziejczyk,
M.Orłowski,
S.Krzywda,
A.Kowalska,
J.Dutko-Gwóźdź,
T.Gwóźdź,
M.Kochman,
M.Jaskólski,
and
A.Ozyhar
(2007).
Novel DNA-binding element within the C-terminal extension of the nuclear receptor DNA-binding domain.
|
| |
Nucleic Acids Res,
35,
2705-2718.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Wjst
(2006).
The vitamin D slant on allergy.
|
| |
Pediatr Allergy Immunol,
17,
477-483.
|
 |
|
|
|
|
 |
S.C.Roemer,
D.C.Donham,
L.Sherman,
V.H.Pon,
D.P.Edwards,
and
M.E.Churchill
(2006).
Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.
|
| |
Mol Endocrinol,
20,
3042-3052.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.E.Donald,
and
E.I.Shakhnovich
(2005).
Predicting specificity-determining residues in two large eukaryotic transcription factor families.
|
| |
Nucleic Acids Res,
33,
4455-4465.
|
 |
|
|
|
|
 |
K.Saavalainen,
S.Pasonen-Seppänen,
T.W.Dunlop,
R.Tammi,
M.I.Tammi,
and
C.Carlberg
(2005).
The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene.
|
| |
J Biol Chem,
280,
14636-14644.
|
 |
|
|
|
|
 |
R.Yasmin,
R.M.Williams,
M.Xu,
and
N.Noy
(2005).
Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer.
|
| |
J Biol Chem,
280,
40152-40160.
|
 |
|
|
|
|
 |
P.L.Shaffer,
A.Jivan,
D.E.Dollins,
F.Claessens,
and
D.T.Gewirth
(2004).
Structural basis of androgen receptor binding to selective androgen response elements.
|
| |
Proc Natl Acad Sci U S A,
101,
4758-4763.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.S.Melvin,
C.Harrell,
J.S.Adelman,
W.L.Kraus,
M.Churchill,
and
D.P.Edwards
(2004).
The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB.
|
| |
J Biol Chem,
279,
14763-14771.
|
 |
|
|
|
|
 |
S.Devarakonda,
J.M.Harp,
Y.Kim,
A.Ozyhar,
and
F.Rastinejad
(2003).
Structure of the heterodimeric ecdysone receptor DNA-binding complex.
|
| |
EMBO J,
22,
5827-5840.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Verrijdt,
K.Schauwaers,
A.Haelens,
W.Rombauts,
and
F.Claessens
(2002).
Functional interplay between two response elements with distinct binding characteristics dictates androgen specificity of the mouse sex-limited protein enhancer.
|
| |
J Biol Chem,
277,
35191-35201.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |